Pt. Meprofarm
- Company typePrivate
- Founded1973
- HeadquartersBandung Dua, Indonesia
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Pt. Meprofarm firmographics
Firmographics- Name
- Pt. Meprofarm
- Legal name
- PT Meprofarm Pharmaceutical Industries
- Website
- https://meprofarm.com
- Company type
- Private
- Founded year
- 1973
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Pt. Meprofarm is headquartered
LocationHeadquarters
- HQ city
- Bandung Dua
- HQ country
- Indonesia
- HQ region
- Asia
Offices1 record
Markets served
Pt. Meprofarm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Branded Pharmaceutical Products: Production and sale of branded pharmaceutical products including Gastrinal HD (antacids/antiulcerants), Boncerin (musculo-skeletal), and various therapeutic categories. Company offers 290+ branded products.
- Generic Pharmaceutical Products: Production and distribution of generic pharmaceutical products. Company offers 50+ generic products.
- Toll Manufacturing: Contract manufacturing services for other pharmaceutical companies using Meprofarm's CPOB-certified facilities.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels5 records
Pt. Meprofarm product offering
Product offeringCore offering
PT Meprofarm manufactures branded pharmaceutical products (290+ SKUs) and generic pharmaceutical products (50+ SKUs) in Indonesia, covering 30+ therapeutic categories including antacids/antiulcerants, musculo-skeletal drugs, nutraceuticals, neurology and pediatric health. The company also offers contract/toll manufacturing services using its CPOB-certified facilities, distributing through national and local distributors to pharmacies, clinics and hospitals across Indonesia.
Product overview
PT Meprofarm is a leading Indonesian pharmaceutical company established in 1973, producing over 290 branded pharmaceutical products and 50+ generic products. The company operates two production facilities: MEPRO-1 (operating since 1995, 40,000 m² land, 25,000 m² building) focused on tablets, syrups, dried syrups, drops, creams, suppositories, ovules, liquid injections, and dry injections; and MEPRO-2 (liquid injection, syrups, creams, and suppositories/ovules). The product portfolio spans across therapeutic categories including Antacids, Antirefluxs Agents & Antiulcerants (featuring Gastrinal HD), Musculo-Skeletal System drugs (featuring Boncerin and OSTENIL), Nutraceuticals & Adjuvant Therapy (featuring Combes and Canergy), neurology products (SIFOLIN), child growth products (CALMAS), and innovative new products (Meprothion SA, ARGIMEP). Products are distributed through 3 national distributors, 10+ local distributors, 9,000+ pharmacies, 1,200+ clinics, and 2,000+ hospitals across Indonesia. The company's tagline is 'Your Wellness is Our Concern.'
Differentiator
Problem solved
Functional benefit
Products and services
- Gastrinal HD A branded antacid/antireflux/antiulcerant pharmaceutical product used for treatment of gastrointestinal disorders, sold to pharmacies, clinics and hospitals in Indonesia.
- Boncerin A branded pharmaceutical product acting on the musculo-skeletal system, indicated for joint and musculoskeletal conditions.
- Combes A branded nutraceutical and adjuvant therapy product developed to support patient therapy alongside primary treatments.
- Canergy A branded pharmaceutical product featured in the nutrition and wellness category to build physician awareness.
- OSTENIL A branded rheumatology pharmaceutical product intended to support therapy and improve quality of life for rheumatology patients.
- SIFOLIN A branded neurology pharmaceutical product introduced at a neurology exhibition to support therapy for neurology patients.
- ARGIMEP A branded pharmaceutical product promoted to healthcare professionals through the Jak Up And Go 2026 industry event.
- CALMAS A branded child growth health product developed in partnership with the KAMAS cooperative founded by the Indonesian Pediatric Association (IDAI).
- Meprothion SA An innovative branded pharmaceutical product introduced at the PERDAWERI Banten 2026 Mini Symposium, representing Meprofarm's innovation-based health solutions.
- Toll Manufacturing Services Contract/toll manufacturing services for other pharmaceutical companies, using Meprofarm's CPOB-certified production facilities for finished dosage forms.
- Branded Pharmaceutical Product Portfolio 290+ branded pharmaceutical products across 30+ therapeutic categories (including antacids/antiulcerants, musculo-skeletal, neurology, nutraceuticals and pediatric) manufactured at CPOB-certified facilities in various dosage forms (tablets, syrups, drops, creams, suppositories, ovules, injections).
- Generic Pharmaceutical Product Portfolio 50+ generic pharmaceutical products distributed alongside the branded line through the same distribution network to Indonesian pharmacies, clinics and hospitals.
Quantifiable outcome
- Serving 9,000+ pharmacies, 1,200+ clinics, and 2,000+ hospitals across Indonesia
- +1 more outcomes
Companies that use Pt. Meprofarm
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles3 records
Pt. Meprofarm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Pt. Meprofarm partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered minor and core.
- PERDAWERI BantenminorPartnership with Indonesian Emergency Medicine Association - Banten chapter for Mini Symposium collaboration. Mepro participated to strengthen network with hospital pharmacy associations and introduce Meprothion SA product
- Puskesmas SiturajaminorHealthcare facility partner for CSR Meprolights Sehatkan Indonesia free medical treatment program in Kaduwulung Village, Sumedang Regency
- UPT CinambominorPublic Health Center partnership for mass vaccination programs targeting residents aged 12-18 years and 18+ years at Mepro Hall Bandung to support government vaccination acceleration program
- KAMAS (Koperasi Anak Mandiri Sejahtera)corePartnership for distribution of CALMAS product, a child growth health product. KAMAS is a cooperative founded by Indonesian Pediatric Association (IDAI). The cooperation aims to increase product awareness among KAMAS members and expand market reach through IDAI-linked healthcare providers.
- TanabecoreStrategic alliance partner in pharmaceutical distribution and product development
- AstellascoreStrategic alliance partner in pharmaceutical distribution and product development
- DexacoreStrategic alliance partner in pharmaceutical distribution and product development
- MerckcoreStrategic alliance partner in pharmaceutical distribution and product development
- LSIminorStrategic alliance partner in pharmaceutical distribution and product development
- FerrisminorStrategic alliance partner in pharmaceutical distribution and product development
- SynmosaminorStrategic alliance partner in pharmaceutical distribution and product development
- TRBminorStrategic alliance partner in pharmaceutical distribution and product development
- IkaminorStrategic alliance partner in pharmaceutical distribution and product development
- LandsonminorStrategic alliance partner in pharmaceutical distribution and product development
- ActavisminorStrategic alliance partner in pharmaceutical distribution and product development
- SohominorStrategic alliance partner in pharmaceutical distribution and product development
- OttominorStrategic alliance partner in pharmaceutical distribution and product development
- MBFminorStrategic alliance partner in pharmaceutical distribution and product development
- PT Great MataramcoreGroup company engaged in pharmaceutical distribution, headquartered in Semarang, Central Java since 1974. Provides nationwide distribution services for medical health products
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Pt. Meprofarm competitors and assessment
Company assessmentBroad incumbents
- PT Kimia Farma: State-owned Indonesian pharmaceutical manufacturer and pharmacy retailer with nationwide distribution. Directly comparable as a domestic pharma manufacturer targeting similar healthcare provider and pharmacy channels.
- PT Kalbe Farma: Indonesia's largest pharmaceutical manufacturer, listed on IDX. Comparable as a domestic pharma manufacturer and distributor with broad therapeutic portfolio and nationwide reach; significantly larger than Meprofarm.
Direct peers
- PT Tempo Scan Pacific: Listed Indonesian pharmaceutical and consumer healthcare manufacturer with branded pharma, OTC, and distribution operations. Comparable in therapeutic diversification and domestic market focus.
- PT Soho Global Health: Indonesian pharmaceutical and nutraceutical manufacturer (Ika, Soho, etc.) and a named Meprofarm partner. Comparable in branded generics and nutraceutical categories with similar Indonesian distribution.
- PT Sanbe Farma: Privately held Indonesian pharmaceutical manufacturer producing branded generics, injections, and oral dosage forms. Comparable in CPOB-certified manufacturing footprint and domestic distribution model.
- PT Phapros: Indonesian pharmaceutical manufacturer with focus on generic and branded generics, listed on IDX. Comparable in product mix, hospital/clinic channel focus, and domestic Indonesian market positioning.
- PT Otto Pharmaceutical Industries: Indonesian pharmaceutical manufacturer and named Meprofarm alliance partner. Comparable in CPOB-compliant manufacturing, branded generics portfolio, and domestic Indonesia distribution.
- PT Dexa Medica: Major Indonesian pharmaceutical manufacturer and one of Meprofarm's named strategic alliance partners. Similar scale, similar branded-generic model, and overlap in distribution channels and therapeutic categories.
- PT Indofarma (Persero): Indonesian state-owned manufacturer focused on generic and branded generic pharmaceuticals. Closely comparable in therapeutic mix (generics, branded generics) and distribution to hospitals/clinics/pharmacies.
Regional players
- PT Merck Sharp Dohme Indonesia: Indonesian subsidiary of Merck & Co. and a named strategic alliance partner of Meprofarm. Comparable through co-development/distribution alliances and presence in the same hospital and pharmacy channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Pt. Meprofarm social profiles
Digital presencePt. Meprofarm compliance and trust
Trust signalCompliance3 records
Pt. Meprofarm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pt. Meprofarm leadership team
Management profileNumber of profiles
Profiles6 records
Pt. Meprofarm subsidiaries and ownership
Company hierarchySubsidiaries3 records
Pt. Meprofarm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pt. Meprofarm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pt. Meprofarm
What does Pt. Meprofarm do?
PT Meprofarm manufactures branded pharmaceutical products (290+ SKUs) and generic pharmaceutical products (50+ SKUs) in Indonesia, covering 30+ therapeutic categories including antacids/antiulcerants, musculo-skeletal drugs, nutraceuticals, neurology and pediatric health. The company also offers contract/toll manufacturing services using its CPOB-certified facilities, distributing through national and local distributors to pharmacies, clinics and hospitals across Indonesia.
Is Pt. Meprofarm a public or private company?
Pt. Meprofarm is a private company. It is classified as family owned and is currently operating.
When was Pt. Meprofarm founded?
Pt. Meprofarm was founded in 1973. It employs 1 to 10 people.
Where is Pt. Meprofarm based?
Pt. Meprofarm is headquartered in Bandung Dua, Indonesia, in the Asia region.
How does Pt. Meprofarm make money?
Three revenue lines are on record. Branded Pharmaceutical Products are the primary driver. The others are generic Pharmaceutical Products and toll Manufacturing.
Who are Pt. Meprofarm's main competitors?
Broad incumbents on record are PT Kimia Farma and PT Kalbe Farma. Direct peers are PT Tempo Scan Pacific, PT Soho Global Health, PT Sanbe Farma, PT Phapros, PT Otto Pharmaceutical Industries, PT Dexa Medica and PT Indofarma (Persero). PT Merck Sharp Dohme Indonesia is listed as a regional player.
Does Pt. Meprofarm have an API?
No public API is recorded for Pt. Meprofarm.